U.S. Office REITs Stock News

If you are wondering whether Clorox stock is starting to offer value again, the recent share price and valuation signals are giving you a fresh set of data points to weigh up. The stock last closed at US$96.82, with returns of 2.8% over the past week and 7.0% over the past month, while being down 4.0% year to date and 17.8% over the past year, as well as 30.9% and 33.6% over the past 3 and 5 years respectively. Recent news coverage has largely focused on Clorox's position in household...

Lithia Motors (LAD) is back in focus after Lithia & Driveway moved up to No. 123 on the 2026 Fortune 500 list, now the highest ranked automotive retailer by revenue. See our latest analysis for Lithia Motors. The recent Fortune 500 recognition comes as the stock posts a 19.65% 1 month share price return and a 24.14% 3 month share price return, even though the year to date share price return is down 5.69% and the 1 year total shareholder return is down 2.49%. The 3 year total shareholder...

Caterpillar Inc.’s board has approved an increase in its quarterly cash dividend to US$1.63 per share, up US$0.12, payable on August 19, 2026 to shareholders of record on July 20, 2026, and shareholders have elected former Duke Energy CEO Lynn J. Good to the board. The higher payout, extending more than three decades of consecutive dividend growth, underlines management’s emphasis on returning cash to investors alongside governance refreshment through an experienced utility and energy...

In early June 2026, Five Below reported that first-quarter net sales rose to US$1,285.6 million and net income to US$123.06 million, and the company raised its full-year 2026 guidance, now expecting US$5.40 billion–US$5.48 billion in net sales and US$480 million–US$502 million in net income. Management linked this upgraded outlook to sharp growth in comparable sales and customer traffic, helped by social-media-fueled product trends and viral celebrity attention that are drawing new shoppers...

If you are wondering whether JPMorgan Chase at around US$320 per share still offers value, the answer depends on how you look at what the current price is actually implying. The stock recently closed at US$320.72, with returns of 2.7% over 7 days, 7.7% over 30 days, a small decline of 1.5% year to date, and 23.4% over the last year, alongside very large multi year gains of around 1.4x over 3 and 5 years. Recent headlines have focused on JPMorgan Chase's role as a major US bank and its...

Honeywell International (HON) has reaffirmed its full year 2026 sales guidance and outlined a preliminary framework for post spin Honeywell Technologies, as the June 29 Aerospace separation approaches and investors reassess the stock. See our latest analysis for Honeywell International. Honeywell’s share price has recovered some ground recently, with a 7 day share price return of 2.96% and year to date share price return of 12.47%. However, the 90 day share price return is down 6.06%,...

Hexcel (NYSE:HXL) has entered a new long term industrial partnership with Deutsche Aircraft to supply composite solutions for the D328eco regional turboprop. The agreement covers advanced composite materials for primary and secondary structures on the D328eco, a next generation aircraft focused on environmental efficiency. The partnership was formalized at a major aerospace event and positions Hexcel within a key European program in regional aviation. For investors watching NYSE:HXL, this...

Wells Fargo stock snapshot after recent performance move Wells Fargo (WFC) has drawn fresh attention after a recent performance move, with the stock last closing at US$83.73. Investors are weighing this level against the bank’s recent returns and current valuation metrics. See our latest analysis for Wells Fargo. The recent 1-day share price return of 1.61% and 30-day share price return of 14.04% sit against a year-to-date share price decline of 12.05%. At the same time, the 1-year total...

Why Tandem Diabetes Care Stock Is Back on Investor Radars Tandem Diabetes Care (TNDM) has drawn fresh attention after recent share price swings, with the stock up about 29% over the past month but down roughly 24% in the past 3 months. See our latest analysis for Tandem Diabetes Care. At a share price of $16.60, Tandem Diabetes Care has seen a 5.06% 1 day share price gain and a 29.49% 30 day share price return. This follows a 24.24% 90 day decline and a 22.97% year to date share price...

Earlier this week, PROG Holdings reported a very strong first quarter, with revenue growth in line with analyst expectations and earnings per share surpassing the high end of its outlook. This upbeat quarterly performance comes despite a longer-term backdrop of flat revenue, declining earnings per share, and falling tangible book value per share, highlighting a tension between near-term execution and underlying fundamentals. With earnings beating guidance but longer-term profitability trends...

Conference spotlight and mixed analyst views put Madrigal Pharmaceuticals (MDGL) in focus Madrigal Pharmaceuticals (MDGL) is back on investors’ radar after recent analyst commentary on its MASH treatment Rezdiffra and plans to showcase fresh clinical and real world data at the upcoming EASL Congress 2026. The stock is also drawing attention ahead of Madrigal’s presentation at the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026, where management is expected to discuss...

JetBlue Airways stock: recent performance snapshot JetBlue Airways (JBLU) has recently drawn investor attention after a period of mixed financial metrics and stock returns, with the shares moving over the past month and past 3 months on shifting expectations. Over the past month, the stock shows a 9.39% gain, with a 17.61% rise over the past 3 months and a 12.08% total return over the past year. These moves sit alongside a weaker 3 year and 5 year record, where total returns declined 37.84%...

In the recent past, Mosaic reported first-quarter 2026 results showing higher year-over-year sales but adjusted earnings that fell short of estimates as input costs surged and gross margins in key segments compressed. Management responded by trimming 2026 capital expenditure guidance by US$250,000,000 while keeping its potash production outlook and main annual financial targets intact, highlighting a focus on cash discipline amid operational pressure. With Mosaic cutting its capital...

In early June 2026, Campbell’s reported third-quarter results showing sales slipping to US$2,366 million from US$2,475 million a year earlier, while net income rose to US$124 million and diluted EPS from continuing operations increased to US$0.41 from US$0.22. At the same time, management froze the dividend, halted buybacks, and doubled down on cost savings and innovation launches to shore up profitability and protect its investment-grade credit rating. Now we’ll examine how these weaker...

In early June 2026, Five9 filed a shelf registration for up to US$70.934 million, covering 2,900,000 shares of common stock in an ESOP-related offering. At the same time, investor focus shifted toward how new Anthropic AI models might affect traditional per-seat SaaS licensing models used by providers like Five9. We’ll examine how concerns about Anthropic’s new AI models and evolving SaaS licensing expectations may influence Five9’s broader investment narrative. Invest in the nuclear...

Dave (DAVE) has drawn fresh attention after expanding its share repurchase authorization to US$300 million and unveiling a new funding arrangement for its ExtraCash receivables with Coastal Community Bank, reshaping its capital and liquidity profile. See our latest analysis for Dave. The share price is now US$286.78 after a 7 day share price return of 11.05% and a 90 day share price return of 35.26%, while the 1 year total shareholder return of 37.72% sits against a five year total...

UiPath (NYSE:PATH) reported that its Maestro platform has been used by One New Zealand Limited to revamp a complex telecom workflow. The deployment enabled near real-time mobile provisioning while keeping existing legacy systems in place. One New Zealand is now extending Maestro to additional mission critical processes after the initial rollout. For investors watching UiPath, this case highlights the company’s core pitch as an orchestration layer for automation and AI agents in large,...

Chinese regulators have reprimanded JD.com and other large e commerce platforms over misleading advertising and irregular discount practices during the 618 shopping festival. Authorities ordered immediate fixes to subsidy campaigns, price disclosures, and consumer protection measures tied to the event. The action signals closer scrutiny of how NasdaqGS:JD structures and markets its major sales promotions. For JD.com, trading at $28.56, the regulatory move comes after a period of weaker...

Wondering whether Globus Medical at around US$80.39 still offers value or if the easy money has already been made? This article breaks down what the current price might be implying about the stock. Globus Medical has returned 0.5% over the past week and 4.9% over the past month, while year to date the stock is down 7.9% and up 36.5% over the past year. Recent coverage has focused on how Globus Medical fits into broader interest in medical technology and healthcare equipment, as investors...

On 12 June 2026, OpenText announced a €105 million investment that will create 400 new jobs in Cork and Galway, expanding its agentic AI, cybersecurity, sovereign cloud, and digital operations capabilities for EMEA clients. This move doubles OpenText’s commitment to Ireland and positions its Irish operations as a core hub for trusted enterprise AI and sovereign cloud services in highly regulated sectors. Next, we’ll examine how this expanded Ireland footprint in agentic AI and sovereign...

Novo Nordisk (NYSE:NVO) reported positive Phase 3 results from its REIMAGINE program for CagriSema, a combination therapy for type 2 diabetes. The trial data showed substantial reductions in HbA1c and body weight in treated patients. Company leadership is outlining plans to build on this platform by expanding into longevity and aesthetics beyond its core diabetes and obesity focus. Novo Nordisk, best known for its diabetes and obesity drugs, is now signaling a broader healthcare vision that...

In recent days, Crescent Energy has been affected by heightened geopolitical tensions in the Middle East, including U.S. military actions involving Iran, supply disruptions, and partial closure of the Strait of Hormuz that have driven sharp swings in oil prices. These events have emphasized how sensitive Crescent Energy’s U.S. shale business is to geopolitical risk and sudden shifts in global oil supply dynamics. We’ll now assess how heightened Middle East supply risks, and the resulting oil...

In recent days, Bloom Energy has been at the center of conflicting reports about a major AI data center project in Cheyenne, Wyoming, after developer Crusoe Energy paused work while utility Black Hills said the multi‑gigawatt campus, including Bloom’s fuel cells, remains on track with a different large‑load customer for service by early 2028. This episode has highlighted how heavily Bloom’s growth story is tied to a small number of very large AI power contracts, sharpening investor focus on...

Dollar General (DG) is back in focus after first quarter sales and earnings surpassed the prior year, prompting higher full year guidance and drawing attention to delivery growth, an expanding customer mix, and a reaffirmed dividend. See our latest analysis for Dollar General. The Q1 beat and raised guidance have coincided with a sharp near term rebound, with a 7 day share price return of 10.70% and 30 day share price return of 12.83%. However, the year to date share price return is still...